Trading-Stocks.de

Normale Version: Achillion Pharmaceuticals, Inc.
Du siehst gerade eine vereinfachte Darstellung unserer Inhalte. Normale Ansicht mit richtiger Formatierung.
Seiten: 1 2
[Bild: chart.ashx?t=ACHN&ty=c&ta=0&p=m&s=l]


[Bild: chart.ashx?t=ACHN&ty=c&ta=0&p=w&s=l]


[Bild: chart.ashx?t=ACHN&ty=c&ta=1&p=d&s=l]
der Vollständigkeit halber...

Achillion Pharmaceuticals wurde von Alexion (ALXN) übernommen - Altaktionäre haben 6,30$ je Anteilsschein erhalten...

$930 million sale of Blue Bell biopharma firm finalized
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) completed its previously disclosed $930 million purchase of Blue Bell-based Achillion Pharmaceuticals.
Achillion (NASDAQ: ACHN) was founded in Connecticut 1998 and has 56 employees. The company, which will now operate as a subsidiary of Alexion, relocated to Montgomery County last year....

...Under the terms of the purchase agreement, Achillion stockholders received $6.30 per share and could net an additional payment of about $140 million if danicopan receives FDA approval. Alexion, which funded the purchase from cash on hand, gets the cash currently on Achillion’s balance sheet. Achillion had about $190 million in cash as of Dec. 31, according to documents filed with the Securities and Exchange Commission.


https://www.bizjournals.com/philadelphia...yptr=yahoo
Seiten: 1 2